Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.

Samsung Biologics Co.,Ltd.

207940

Rang in aandelen #498
Samsung Biologics Co.,Ltd., established in 2011 and headquartered in Incheon,... Samsung Biologics Co.,Ltd., established in 2011 and headquartered in Incheon, South Korea, provides contract services for biopharmaceutical products. The company's operations are divided into two main segments: Contract Manufacturing Organization (CMO) and Contract Development Organization (CDO). Its CDO services cover areas such as cell line development, optimization of upstream and downstream processes, and the formulation of analytical methods and final products. For CMO, the company offers aseptic filling, lyophilization, finishing, storage, shipping, and various associated support services. Additionally, it delivers comprehensive quality assurance, quality control, biosafety, and analytical testing. Samsung Biologics is also involved in creating and launching biosimilar drugs, alongside manufacturing mammalian cell-based antibody medications.
Aandeelprijs
$1,028.49
Marktkapitalisatie
$47.88B
Verandering (1 dag)
-3.67%
Verandering (1 jaar)
-18.37%
Land
KR
Handel Samsung Biologics Co.,Ltd. (207940)

Categorie

Healthcare
Aandelsplitsingen voor Samsung Biologics Co.,Ltd. (207940)
Het aandeel Samsung Biologics Co.,Ltd. (symbool: 207940) heeft in totaal 1 splitsingen ondergaan.
De meest recente splitsing vond plaats op Oct 30, 2025.
Eén aandeel 207940 dat vóór Oct 30, 2025 werd gekocht, staat nu gelijk aan 0.650391 aandelen 207940.
Lijst van aandelen splitsingen
Jaar Splitsing Vermenigvuldiging Cumulatieve vermenigvuldiging
2025-10-30 650391:1000000 x0.650391 x0.650391
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
Bedrijf Aantal aandelen splitsingen Cumulatieve vermenigvuldiging Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 0 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 1 x3
AU
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 1 x100
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL